Anderson Kenneth C.'s Insider Trades & SAST Disclosures
Anderson Kenneth C.'s most recent trade in C4 Therapeutics Inc was a trade of 7,841 Common Stock done at an average price of $1.4 . Disclosure was reported to the exchange on April 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Anderson Kenneth C..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 1.44 per share. | 01 Apr 2025 | 7,841 | 127,609 | - | 1.4 | 11,252 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 3.66 per share. | 02 Jan 2025 | 3,074 | 119,768 | - | 3.7 | 11,251 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 5.56 per share. | 01 Oct 2024 | 2,023 | 116,694 | - | 5.6 | 11,248 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 4.85 per share. | 01 Jul 2024 | 2,320 | 114,671 | - | 4.9 | 11,252 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 32,500 | 32,500 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 8.10 per share. | 01 Apr 2024 | 1,389 | 112,351 | - | 8.1 | 11,251 | Common Stock |
| C4 Therapeutics Inc | Anderson Kenneth C. | Director | Grant, award, or other acquisition of securities at price $ 6.52 per share. | 02 Jan 2024 | 1,725 | 110,962 | - | 6.5 | 11,247 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 2.83 per share. | 03 Jul 2023 | 3,976 | 102,620 | - | 2.8 | 11,252 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 26,000 | 26,000 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 3.20 per share. | 03 Apr 2023 | 3,516 | 98,644 | - | 3.2 | 11,251 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 444 | 890 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.98 per share. | 06 Jan 2023 | 444 | 95,128 | - | 5.0 | 2,211 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.11 per share. | 06 Jan 2023 | 268 | 94,684 | - | 2.1 | 565 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 268 | 1,067 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 6.38 per share. | 03 Jan 2023 | 1,568 | 94,416 | - | 6.4 | 10,004 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 8.69 per share. | 03 Oct 2022 | 1,150 | 92,848 | - | 8.7 | 9,994 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 445 | 1,334 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.98 per share. | 03 Oct 2022 | 445 | 91,698 | - | 5.0 | 2,216 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 267 | 1,335 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.11 per share. | 03 Oct 2022 | 267 | 91,253 | - | 2.1 | 563 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.98 per share. | 15 Jul 2022 | 889 | 90,986 | - | 5.0 | 4,427 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 889 | 1,779 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 535 | 1,602 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.11 per share. | 15 Jul 2022 | 535 | 90,097 | - | 2.1 | 1,129 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 8.03 per share. | 01 Jul 2022 | 1,246 | 89,562 | - | 8.0 | 10,005 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 23,500 | 23,500 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 26.46 per share. | 04 Apr 2022 | 341 | 88,316 | - | 26.5 | 9,023 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2022 | 1,334 | 2,668 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.98 per share. | 26 Jan 2022 | 1,334 | 87,975 | - | 5.0 | 6,643 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.11 per share. | 26 Jan 2022 | 803 | 86,641 | - | 2.1 | 1,694 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2022 | 803 | 2,137 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 31.58 per share. | 04 Jan 2022 | 278 | 85,838 | - | 31.6 | 8,779 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 44.99 per share. | 04 Oct 2021 | 194 | 85,560 | - | 45.0 | 8,728 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 39.72 per share. | 02 Jul 2021 | 220 | 85,366 | - | 39.7 | 8,738 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 23,500 | 23,500 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Apr 2021 | 2,278 | 47,316 | - | 0 | Common Stock | |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Apr 2021 | 2,278 | 84,435 | - | 0 | Common Stock | |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2021 | 444 | 4,002 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.98 per share. | 14 Apr 2021 | 444 | 85,146 | - | 5.0 | 2,211 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2021 | 267 | 2,940 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.11 per share. | 14 Apr 2021 | 267 | 84,702 | - | 2.1 | 563 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 37.51 per share. | 05 Apr 2021 | 233 | 82,157 | - | 37.5 | 8,740 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.98 per share. | 22 Jan 2021 | 889 | 81,924 | - | 5.0 | 4,427 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2021 | 889 | 4,446 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2021 | 538 | 3,207 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.11 per share. | 22 Jan 2021 | 538 | 80,914 | - | 2.1 | 1,135 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2021 | 121 | 0 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.11 per share. | 22 Jan 2021 | 121 | 81,035 | - | 2.1 | 255 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | 06 Oct 2020 | 347,840 | 0 | - | - | Series A Preferred Stock | ||
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | 06 Oct 2020 | 347,840 | 0 | - | - | Series A Preferred Stock | ||
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | 06 Oct 2020 | 152,160 | 0 | - | - | Series A Preferred Stock | ||
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | 06 Oct 2020 | 152,160 | 0 | - | - | Series A Preferred Stock | ||
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | 06 Oct 2020 | 142,857 | 0 | - | - | Series B Preferred Stock | ||
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | 06 Oct 2020 | 142,857 | 0 | - | - | Series B Preferred Stock | ||
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | 06 Oct 2020 | 41,244 | 63,543 | - | - | Common Stock | ||
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | 06 Oct 2020 | 41,244 | 63,543 | - | - | Common Stock | ||
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | 06 Oct 2020 | 18,040 | 45,038 | - | - | Common Stock | ||
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | 06 Oct 2020 | 18,040 | 80,376 | - | - | Common Stock | ||
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | 06 Oct 2020 | 16,939 | 16,939 | - | - | Common Stock | ||
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | 06 Oct 2020 | 16,939 | 16,939 | - | - | Common Stock | ||
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 17,786 | 17,786 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges